Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
letter
. 1981 Mar;11(3):303–304. doi: 10.1111/j.1365-2125.1981.tb00538.x

Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects.

W A McAllister, D M Mitchell, J V Collins
PMCID: PMC1401628  PMID: 7194101

Full text

PDF
303

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angeli A., Frajria R., De Paoli R., Fonzo D., Ceresa F. Diurnal variation of prednisolone binding to serum corticosteroid-binding globulin in man. Clin Pharmacol Ther. 1978 Jan;23(1):47–53. doi: 10.1002/cpt197823147. [DOI] [PubMed] [Google Scholar]
  2. Chakraborty J., English J., Marks V., Dumasia M. C., Chapman D. J. A radioimmunoassay method for prednisolone: comparison with the competitive protein binding method. Br J Clin Pharmacol. 1976 Oct;3(5):903–906. doi: 10.1111/j.1365-2125.1976.tb00645.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DAY W. A. Endometriosis involving the rectum and rectosigmoid. Rocky Mt Med J. 1962 May;59:38–40. [PubMed] [Google Scholar]
  4. Henderson R. G., Wheatley T., English J., Chakraborty J., Marks V. Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone. Br Med J. 1979 Jun 9;1(6177):1534–1536. doi: 10.1136/bmj.1.6177.1534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. NICHOLS T., NUGENT C. A., TYLER F. H. DIURNAL VARIATION IN SUPPRESSION OF ADRENAL FUNCTION BY GLUCOCORTICOIDS. J Clin Endocrinol Metab. 1965 Mar;25:343–349. doi: 10.1210/jcem-25-3-343. [DOI] [PubMed] [Google Scholar]
  6. Poley G. E., Jr, Shively C. A., Vesell E. S. Diurnal rhythms of aminopyrine metabolism: failure to sleep deprivation to affect them. Clin Pharmacol Ther. 1978 Dec;24(6):726–732. doi: 10.1002/cpt1978246726. [DOI] [PubMed] [Google Scholar]
  7. Segre E. J., Klaiber E. L. Therapeutic utilization of the diurnal variation in pituitary-adrenocortical activity. Calif Med. 1966 May;104(5):363–365. [PMC free article] [PubMed] [Google Scholar]
  8. Tanner A., Bochner F., Caffin J., Halliday J., Powell L. Dose-dependent prednisolone kinetics. Clin Pharmacol Ther. 1979 May;25(5 Pt 1):571–578. doi: 10.1002/cpt1979255part1571. [DOI] [PubMed] [Google Scholar]
  9. Uribe M., Schalm S. W., Summerskill W. H., Go V. L. Oral prednisone for chronic active liver disease: dose responses and bioavailability studies. Gut. 1978 Dec;19(12):1131–1135. doi: 10.1136/gut.19.12.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Vesell E. S., Shively C. A., Passananti G. T. Temporal variations of antipyrine half-life in man. Clin Pharmacol Ther. 1977 Dec;22(6):843–852. doi: 10.1002/cpt1977226843. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES